Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBC.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.362.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.362.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.162NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.162NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Y.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Y.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.86NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.86NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.154NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.154NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.4.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.4.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
CH.1.1.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.193NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-18487.6South Korea
B.1.1.193NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FP.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FP.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DA.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DA.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.439NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.439NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.408NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.408NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.256NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.256NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.7 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.7 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.460NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.460NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.262NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.262NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.3 (Omicron)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.3 (Omicron)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.16.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.16.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.372NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.372NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.425NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.425NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
B.1.1.144NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used